Clinical and Immune Impact of Mycobacterium bovis BCG Vaccination Scarring

The World Health Organization recommends Mycobacterium bovis BCG vaccination in areas of high tuberculosis prevalence. BCG's clinical and immune effects, not necessarily Mycobacterium tuberculosis specific, are unclear. BCG vaccine scarring often is used as a surrogate marker of vaccination or...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jason, Janine, Archibald, Lennox K., Nwanyanwu, Okey C., Kazembe, Peter N., Chatt, Julie A., Norton, Elizabeth, Dobbie, Hamish, Jarvis, William R.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2002
Sujets:
Microbial Immunity and Vaccines
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC130324/
https://ncbi.nlm.nih.gov/pubmed/12379697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.70.11.6188-6195.2002
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires